Trials / Unknown
UnknownNCT02251847
The Efficacy and Safety of a Combination Therapy of Rosuvastatin and Ezetimibe Versus Monotherapy of Rosuvastatin in Hypercholesterolemia Patients
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 400 (estimated)
- Sponsor
- IlDong Pharmaceutical Co Ltd · Industry
- Sex
- All
- Age
- 19 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate efficacy and safety of a combination therapy of rosuvastatin and ezetimibe versus monotherapy of rosuvastatin in hypercholesterolemia patients
Detailed description
To evaluate efficacy and safety of a combination therapy of rosuvastatin and ezetimibe versus monotherapy of rosuvastatin in hypercholesterolemia patients
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Rosuvastatin/Ezetimibe | Rosuvastatin 5mg |
Timeline
- Start date
- 2014-07-01
- Primary completion
- 2015-07-01
- First posted
- 2014-09-29
- Last updated
- 2014-09-29
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02251847. Inclusion in this directory is not an endorsement.